arrow
T

Tessa Prince

University of Liverpool
H指数:29
被引数:5,945

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genomic changes of Lassa virus associated with mammalian host adaptation

与哺乳动物宿主适应性相关的拉沙病毒基因组变化

2025-05-150
OA
Aetiologies, neuroradiological features, and risk factors for mortality and long-term neurosequelae of febrile coma in Malawian children: a prospective cohort study

发热性昏迷的病因学、神经放射学特征,以及死亡和长期神经后遗症的风险因素(马拉维儿童):一项前瞻性队列研究

2025-04-220
OA
SARS-CoV-2 population dynamics in immunocompetent individuals in a closed transmission chain shows genomic diversity over the course of infection
2024-07-161
OAAI
Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19
2024-05-283
OAAI
The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection
2023-03-1313
OAAI
Analysis of SARS-CoV-2 in Nasopharyngeal Samples from Patients with COVID-19 Illustrates Population Variation and Diverse Phenotypes, Placing the Growth Properties of Variants of Concern in Context with Other Lineages
MSPHERE
IF3.1
2022-06-2911
OAAI
Analysis of SARS-CoV-2 known and novel subgenomic mRNAs in cell culture, animal model, and clinical samples using LeTRS, a bioinformatic tool to identify unique sequence identifiers

使用LeTRS分析细胞培养,动物模型和临床样品中SARS-CoV-2已知和新的亚基因组mrna,这是一种用于识别独特序列标识符的生物信息学工具

2022-05-2611
OAAI
Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical Trial (SARS-CoV-2)
2022-05-1130
OAAI
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19
2021-09-2294
OAAI